Login Register
Feed Contact Us
Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Advanced Search
Back
4Engineers
· Chemical Engineering Online
AI summary

Thermo Fisher Scientific has completed the sale of its microbiology business to Astorg, a pan-European private equity firm, for about $1.075 billion, including cash and a $50 million seller note. The divested unit provides antimicrobial susceptibility testing and culture media solutions for clinical and pharmaceutical applications.

What impact do you think this divestiture will have on competition and innovation in clinical microbiology testing?

Thermo Fisher Scientific completes sale of its microbiology business

This article was originally posted on chemengonline.com.
View article ->

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and […]

The post Thermo Fisher Scientific completes sale of its microbiology business appeared first on Chemical Engineering.

Login to comment

Login

Related Conversations

Recent Conversations

Your Conversations

Report content
Reason Description